Pearson J. Michael
Insider CIK 1426004 · VRX Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRX Valeant Pharmaceuticals In | F Tax w/h deriv | 2015-12-31 | 2016-01-05 | 14,412 | $73.77 | $1.06M | 465,588 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2015-11-05 | 2015-11-09 | 800,345 | $76.66 | $61.35M | 1,864,664 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2015-11-05 | 2015-11-09 | 350,000 | $84.26 | $29.49M | 1,514,664 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2015-11-05 | 2015-11-09 | 147,054 | $74.67 | $10.98M | 2,665,009 | SEC↗ |
| VRX Valeant Pharmaceuticals In | G Gift | 2015-02-26 | 2015-03-02 | 86,641 | — | $0 | 2,812,063 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2015-01-07 | 2015-01-09 | 450,000 | — | $0 | 450,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2014-03-11 | 2014-03-13 | 502,996 | — | $0 | 502,996 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-12-14 | 2013-12-17 | 184,247 | $81.41 | $15.00M | 4,025,498 | SEC↗ |
| VRX Valeant Pharmaceuticals In | G Gift | 2012-12-14 | 2012-12-19 | 175,000 | — | $0 | 6,287,643 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-24 | 2012-10-26 | 25,787 | — | $0 | 6,462,643 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-04-24 | 2012-04-26 | 101,877 | — | $0 | 6,488,430 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-04-12 | 2012-04-16 | 502,998 | — | $0 | 6,597,601 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-04-12 | 2012-04-16 | 7,294 | — | $0 | 6,590,307 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-02-01 | 2012-02-03 | 49,539 | — | $0 | 6,094,603 | SEC↗ |